Newsfeeds - Spark Newswire

2 minute read

Clene Highlights Presentation Of Phase 2 CNM-Au8 Target Engagement Data At Int’l. Parkinson, Movement Disorder Society Congress

Today, 10:45 PM

CNM-Au8® , a catalytically active gold nanocrystal suspension, significantly improved brain energetic metabolism in Parkinson’s patients SALT LAKE CITY, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Clene Inc.

CLNN

1 minute read

Clene Completes Final Patient Visit In Phase 2 RESCUE-ALS Study: Topline Data Readout Expected Q4 2021

By Benzinga Newsdesk

Today, 10:45 PM

Clene Completes Final Patient Visit in Phase 2 RESCUE-ALS Study: Topline Data Readout Expected Q4 2021

CLNN

2 minute read

News

Clene Reports 2 New Leases To Materially Expand Manufacturing Capacity Of Its CNM-Au8

By Benzinga Newsdesk

Today, 10:45 PM

Clene Inc. (NASDAQ:CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of

CLNN

1 minute read

Clene Q2 EPS $(0.05) Beats $(0.15) Estimate, Sales $201.00K Beat $60.00K Estimate

By Benzinga Newsdesk

Today, 10:45 PM

Clene (NASDAQ:CLNN) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.15) by 66.67 percent. The company reported quarterly sales of $201.00 thousand which beat the analyst

CLNN

1 minute read

Clene’s Stock Gain As Its Nanotherapeutic Improves Energy Production, Brain Utilization In Patients With Parkinson’s, Multiple Sclerosis

By Vandana Singh

Today, 10:45 PM

Clene Inc (NASDAQ:CLNN) has shared positive top-line results from the Phase 2 REPAIR trials investigating the improvement of brain energetic metabolism…

CLNN

5 minute read

FDA
News

Clene Reports Top-line Results From Phase 2 REPAIR Clinical Trials In Parkinson’s Disease And Multiple Sclerosis

By Benzinga Newsdesk

Today, 10:45 PM

Clene Inc. (NASDAQ:CLNN) along with its subsidiaries "Clene" and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of

CLNN

4 minute read

54 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:45 PM

Gainers Sight Sciences, Inc. (NASDAQ: SGHT) shares jumped 39.6% to settle at $33.50 on Thursday as the company priced its IPO at $24 per share.

AACG

3 minute read

32 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 10:45 PM

Gainers ATA Creativity Global (NASDAQ: AACG) shares jumped 37.8% to $4.1050.

AACG

5 minute read

55 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:45 PM

Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares gained 37.6% to settle at $13.20 on Wednesday. SGOCO Group regained compliance with Nasdaq's listing standards on July 12 by filing its FY20 20-F.

AEHL

4 minute read

Uncategorized

58 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:45 PM

Gainers Peabody Energy Corporation (NYSE: BTU) shares gained 32.3% to settle at $8.60 on Monday.

AHT